146 related articles for article (PubMed ID: 38728253)
1. 4-hydroxysesamin protects rat with right ventricular failure due to pulmonary hypertension by inhibiting JNK/p38 MAPK signaling.
Zhang L; Gu X
Aging (Albany NY); 2024 May; 16(9):8142-8154. PubMed ID: 38728253
[TBL] [Abstract][Full Text] [Related]
2. Notch4 mediates vascular remodeling via ERK/JNK/P38 MAPK signaling pathways in hypoxic pulmonary hypertension.
Guo M; Zhang M; Cao X; Fang X; Li K; Qin L; He Y; Zhao J; Xu Y; Liu X; Li X
Respir Res; 2022 Jan; 23(1):6. PubMed ID: 35016680
[TBL] [Abstract][Full Text] [Related]
3. Icotinib Attenuates Monocrotaline-Induced Pulmonary Hypertension by Preventing Pulmonary Arterial Smooth Muscle Cell Dysfunction.
Peng LY; Yu M; Yang MX; Liu P; Zhou H; Huang W; Kong H; Xie WP
Am J Hypertens; 2020 Aug; 33(8):775-783. PubMed ID: 32301965
[TBL] [Abstract][Full Text] [Related]
4. Fluoxetine protects against monocrotaline-induced pulmonary arterial remodeling by inhibition of hypoxia-inducible factor-1α and vascular endothelial growth factor.
Han DD; Wang Y; Zhang XH; Liu JR; Wang HL
Can J Physiol Pharmacol; 2012 Apr; 90(4):445-54. PubMed ID: 22448962
[TBL] [Abstract][Full Text] [Related]
5. PAR-2 inhibition reverses experimental pulmonary hypertension.
Kwapiszewska G; Markart P; Dahal BK; Kojonazarov B; Marsh LM; Schermuly RT; Taube C; Meinhardt A; Ghofrani HA; Steinhoff M; Seeger W; Preissner KT; Olschewski A; Weissmann N; Wygrecka M
Circ Res; 2012 Apr; 110(9):1179-91. PubMed ID: 22461388
[TBL] [Abstract][Full Text] [Related]
6. Inhalation of the BK(Ca)-opener NS1619 attenuates right ventricular pressure and improves oxygenation in the rat monocrotaline model of pulmonary hypertension.
Revermann M; Neofitidou S; Kirschning T; Schloss M; Brandes RP; Hofstetter C
PLoS One; 2014; 9(1):e86636. PubMed ID: 24497961
[TBL] [Abstract][Full Text] [Related]
7. Calcineurin/NFAT Signaling Modulates Pulmonary Artery Smooth Muscle Cell Proliferation, Migration and Apoptosis in Monocrotaline-Induced Pulmonary Arterial Hypertension Rats.
He RL; Wu ZJ; Liu XR; Gui LX; Wang RX; Lin MJ
Cell Physiol Biochem; 2018; 49(1):172-189. PubMed ID: 30134231
[TBL] [Abstract][Full Text] [Related]
8. Let-7a-transfected mesenchymal stem cells ameliorate monocrotaline-induced pulmonary hypertension by suppressing pulmonary artery smooth muscle cell growth through STAT3-BMPR2 signaling.
Cheng G; Wang X; Li Y; He L
Stem Cell Res Ther; 2017 Feb; 8(1):34. PubMed ID: 28187784
[TBL] [Abstract][Full Text] [Related]
9. The effect of activated κ-opioid receptor (κ-OR) on the role of calcium sensing receptor (CaSR) in preventing hypoxic pulmonary hypertension development.
Li J; Jia M; Liu M; Cao Z; Wang X; Feng N; Gu X; Zhang S; Fan R; Guo H; Wang Y; Liu M; Pei J
Biomed Pharmacother; 2020 May; 125():109931. PubMed ID: 32066040
[TBL] [Abstract][Full Text] [Related]
10. Enhanced Ca(2+)-sensing receptor function in idiopathic pulmonary arterial hypertension.
Yamamura A; Guo Q; Yamamura H; Zimnicka AM; Pohl NM; Smith KA; Fernandez RA; Zeifman A; Makino A; Dong H; Yuan JX
Circ Res; 2012 Aug; 111(4):469-81. PubMed ID: 22730443
[TBL] [Abstract][Full Text] [Related]
11. IGF-1 induces iNOS expression via the p38 MAPK signal pathway in the anti-apoptotic process in pulmonary artery smooth muscle cells during PAH.
Jin C; Guo J; Qiu X; Ma K; Xiang M; Zhu X; Guo J
J Recept Signal Transduct Res; 2014 Aug; 34(4):325-31. PubMed ID: 24673524
[TBL] [Abstract][Full Text] [Related]
12. Cyanidin‑3‑O‑β‑glucoside protects against pulmonary artery hypertension induced by monocrotaline via the TGF‑β1/p38 MAPK/CREB signaling pathway.
Ouyang S; Chen W; Gaofeng Z; Changcheng L; Guoping T; Minyan Z; Yang L; Min Y; Luo J
Mol Med Rep; 2021 May; 23(5):. PubMed ID: 33760143
[TBL] [Abstract][Full Text] [Related]
13. Low-dose fluvastatin reverses the hypoxic pulmonary adventitial fibroblast phenotype in experimental pulmonary hypertension.
Carlin CM; Celnik DF; Pak O; Wadsworth R; Peacock AJ; Welsh DJ
Am J Respir Cell Mol Biol; 2012 Aug; 47(2):140-8. PubMed ID: 22383583
[TBL] [Abstract][Full Text] [Related]
14. Resveratrol reverses monocrotaline-induced pulmonary vascular and cardiac dysfunction: a potential role for atrogin-1 in smooth muscle.
Paffett ML; Lucas SN; Campen MJ
Vascul Pharmacol; 2012; 56(1-2):64-73. PubMed ID: 22146233
[TBL] [Abstract][Full Text] [Related]
15. TRB3 mediates vascular remodeling by activating the MAPK signaling pathway in hypoxic pulmonary hypertension.
Cao X; Fang X; Guo M; Li X; He Y; Xie M; Xu Y; Liu X
Respir Res; 2021 Dec; 22(1):312. PubMed ID: 34906150
[TBL] [Abstract][Full Text] [Related]
16. Osthole inhibits cell proliferation by regulating the TGF-β1/Smad/p38 signaling pathways in pulmonary arterial smooth muscle cells.
Yue Y; Li YQ; Fu S; Wu YT; Zhu L; Hua L; Lv JY; Li YL; Yang DL
Biomed Pharmacother; 2020 Jan; 121():109640. PubMed ID: 31810114
[TBL] [Abstract][Full Text] [Related]
17. Interferon regulatory factor 7 inhibits rat vascular smooth muscle cell proliferation and inflammation in monocrotaline-induced pulmonary hypertension.
Deng Y; Guo SL; Li JQ; Xie SS; Zhou YC; Wei B; Wang Q; Wang F
Life Sci; 2021 Jan; 264():118709. PubMed ID: 33152351
[TBL] [Abstract][Full Text] [Related]
18. Exosomes derived from mesenchymal stromal cells exert a therapeutic effect on hypoxia-induced pulmonary hypertension by modulating the YAP1/SPP1 signaling pathway.
Chen YX; Deng ZH; Xue-Gao ; Qiang-Du ; Juan-Yin ; Chen GH; Li JG; Zhao YM; Zhang HT; Zhang GX; Qian JX
Biomed Pharmacother; 2023 Dec; 168():115816. PubMed ID: 37918254
[TBL] [Abstract][Full Text] [Related]
19. Glycyrrhizin, inhibitor of high mobility group box-1, attenuates monocrotaline-induced pulmonary hypertension and vascular remodeling in rats.
Yang PS; Kim DH; Lee YJ; Lee SE; Kang WJ; Chang HJ; Shin JS
Respir Res; 2014 Nov; 15():148. PubMed ID: 25420924
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic Potential of Regorafenib-A Multikinase Inhibitor in Pulmonary Hypertension.
Veeroju S; Kojonazarov B; Weiss A; Ghofrani HA; Weissmann N; Grimminger F; Seeger W; Novoyatleva T; Schermuly RT
Int J Mol Sci; 2021 Feb; 22(3):. PubMed ID: 33540939
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
